サハラ以南のアフリカの"一般的で治癒可能な"GICCインデックスがんの子供の生存に対する治療放棄の重要な影響 - マルチセンターの見通し CANCaReアフリカ研究
Mulugeta Yimer1, Diriba Fufa2, Festus Njuguna3
1Unit of Pediatric Hematology Oncology, University of Gondar Specialized Hospital, Gondar, Ethiopia.
Pediatric blood & cancer
|September 3, 2025
まとめ
サハラ以南のアフリカでは 2歳児の生存率は約41%です 治療中止を防ぐことで これらの一般的な小児がんの生存率が ほぼ2倍になる可能性があります
科学分野:
- 小児腫瘍学
- 世界保健
- 癌 流行病学
背景:
- 世界保健機関 (WHO) の児童がん対策グローバルイニシアチブは 児童がんの生存率を60%にすることを目指しています
- この研究はサハラ以南のアフリカで 治療可能な5つの小児がんの生存率と 治療放棄率に焦点を当てています
研究 の 目的:
- ブルキットリンパ腫,急性リンパ性白血病,ウィルムズ腫瘍,網膜芽細胞腫,ホジキンリンパ腫を患った子どもの2年生存期 (EFS) を記述する.
- この集団におけるEFSに対する治療中止 (TxA) の影響を評価する.
主な方法:
- 2022年1月から12月までの間に5つの特定のがんと新たに診断された366人の子供 (<16歳) を対象とした多センター,前向きな観察コホート研究が行われました.
- この研究では,マラウィ,エチオピア,ガーナ,ケニア,ウガンダ,カメルーンの7つの病院から参加者が含まれていました.
- 2年間の無事生存率と治療中止率を分析した.
主要な成果:
- 治療中止は24%の患者で,最も高い割合は (38%) 網膜芽細胞腫で観察されました.
- 2年間のEFSは全体的に40. 8%であったが,治療中止の症例を検閲すると59. 2%に改善した.
- 急性リンパ性白血病の 27. 4% からホジキンリンパ腫の 68. 5% に及ぶ.
結論:
- サハラ以南のアフリカでは 治療可能な小児がんの生存率は極めて低く 2歳では平均約41%です
- 治療中止は重要な要因で,患者の約25%に影響を与え,生存率を大幅に低下させます.
- 治療中断を防ぐための介入戦略は極めて重要であり,WHOの目標である平均生存率を60%に引き上げる可能性がある.
関連する概念動画
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K
01:20Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280